Recently, Scivita Medical Technology Co., Ltd. (“Scivita Medical”) and Boston Scientific Corporation (NYSE: BSX), a leading global medical technology company, joined hands again to sign an expanded strategic cooperation arrangement.

最近，Scivita Medical Technology Co.，Ltd.（“Scivita Medical”）和全球领先的医疗技术公司波士顿科学公司（NYSE:BSX）再次携手签署了扩大战略合作安排。

A photo of signatures being signed at the signing ceremony

签名仪式上签名的照片

The Strategic Cooperation Arrangement Signing Ceremony between Scivita Medical and Boston Scientific

Scivita Medical与Boston Scientific战略合作协议签署仪式

The introduction of iterative endoscopic technology has brought about a positive transformation in the field of endoscopy, making it an interventional tool that combines diagnosis and treatment. Single-use videoscopes are considered a solution to cross-infection in traditional endoscopy, making them a promising solution for the future medical endoscope market.

迭代内窥镜技术的引入带来了内窥镜领域的积极变革，使其成为诊断和治疗相结合的介入工具。一次性使用视频内窥镜被认为是传统内窥镜交叉感染的解决方案，使其成为未来医疗内窥镜市场的有前途的解决方案。

The global market value of single-use videoscope was USD 0.5 billion in 2020, and is estimated to increase to USD 9.2 billion in 2030, according to Frost & Sullivan..

Frost&Sullivan的数据显示，2020年，一次性视频示波器的全球市场价值为5亿美元，预计到2030年将增至92亿美元。。

Scivita Medical is a medical device company that provides minimally invasive diagnosis and treatment solutions, and focuses on research, development and commercialization of medical endoscopes and related products. The company has made globalization its strategic goal. Scivita Medical is making progress towards this goal through strategic cooperations with Chinese enterprises and multinational companies, like Boston Scientific..

Scivita Medical是一家提供微创诊断和治疗解决方案的医疗器械公司，专注于医用内窥镜及相关产品的研究、开发和商业化。该公司已将全球化作为其战略目标。Scivita Medical通过与中国企业和跨国公司（如Boston Scientific）的战略合作，正在朝着这一目标取得进展。。

Under the arrangement, Scivita Medical will expand its relationship with Boston Scientific for strategic co-development and global distribution activities. Such activities may include collaboration on the co-development of future endoscopic devices, and global distribution opportunities for Scivita Medical’s single-use endoscope and imaging devices.

根据安排，Scivita Medical将扩大与Boston Scientific的战略合作开发和全球分销活动关系。这些活动可能包括合作开发未来内窥镜设备，以及Scivita Medical一次性内窥镜和成像设备的全球分销机会。

It is expected that this expanded arrangement will help bring Scivita Medical products to more hospitals and patients throughout China and other global geographies..

预计这一扩大的安排将有助于将Scivita医疗产品带到中国和其他全球地区的更多医院和患者。。

Dr. Chin To (left), Co-founder, General Manager, and Chief Technology Officer of Scivita Medical

Chin To博士（左），Scivita Medical联合创始人、总经理兼首席技术官

Mike Jones (right), senior vice president and president, Endoscopy, Boston Scientific

Mike Jones（右），波士顿科学公司高级副总裁兼内窥镜检查总裁

“We are excited to further our relationship with Scivita Medical which we anticipate will help provide physicians with more device options in geographies around the world,” said Mike Jones, senior vice president and president, Endoscopy, Boston Scientific. “We look forward to successfully building on that relationship with this new arrangement.”.

波士顿科学公司（Boston Scientific）内窥镜检查高级副总裁兼总裁迈克·琼斯（Mike Jones）表示：“我们很高兴与Scivita Medical进一步发展关系，我们预计这将有助于为世界各地的医生提供更多的设备选择。”。“我们期待着通过这一新安排成功地建立这种关系。”。

“I am delighted to announce the deepened collaboration between Scivita Medical and Boston Scientific, a leading global medical technology company. This strengthened relationship will help us combine our core strengths and expertise to deliver high-quality single-use endoscope solutions to doctors and patients in various regions across the globe.

“我很高兴宣布Scivita Medical与全球领先的医疗技术公司Boston Scientific之间的合作加深。这种加强的关系将有助于我们结合我们的核心优势和专业知识，为全球各地的医生和患者提供高质量的一次性内窥镜解决方案。

Working with a company like Boston Scientific is crucial to Scivita Medical’s globalization strategy. We will continue to focus on innovative research and development, expand our business cooperation models, and provide more innovative, high-quality, and accessible products to benefit doctors and patients worldwide,” said that Dr.

与波士顿科学（Boston Scientific）这样的公司合作对于Scivita Medical的全球化战略至关重要。我们将继续专注于创新研发，扩大我们的商业合作模式，并提供更多创新、高质量和易获得的产品，使全球医生和患者受益。

Chin To, Co-founder, General Manager, and Chief Technology Officer of Scivita Medical..

Chin To，Scivita Medical的联合创始人、总经理兼首席技术官。。

About Scivita Medical

关于Scivita Medical

Founded in 2016, Scivita Medical is a medical device company that provides minimally invasive diagnosis and treatment solutions, and focuses on research, development and commercialization of medical endoscopes and related products. Scivita Medical takes ‘Globalization’ as its core strategy and has established R&D centers both in China and Japan.

Scivita Medical成立于2016年，是一家提供微创诊断和治疗解决方案的医疗器械公司，专注于医用内窥镜及相关产品的研究、开发和商业化。Scivita Medical以“全球化”为核心战略，在中国和日本都建立了研发中心。

With solid in-house R&D capabilities, Scivita Medical has established a unique technology platform built upon five synergistic core technologies, and built a comprehensive portfolio of endoscope products and therapeutic products covering all types of endoscope procedures conducted by the various clinical departments, to address diverse medical needs.

凭借强大的内部研发能力，Scivita Medical建立了一个基于五项协同核心技术的独特技术平台，并建立了涵盖各种临床部门进行的所有类型内窥镜手术的内窥镜产品和治疗产品的综合组合，以满足不同的医疗需求。

Adhering to its value of ‘Clinical Focus’ ‘Collaborative Innovation’ ‘People Oriented’ ‘Excellence & Efficiency’, Scivita Medical will continuously upgrade its core technologies, improve market penetration with excellent products aiming to become the preferred brand, trusted by doctors and patients around the world..

Scivita Medical秉承“临床聚焦”、“协同创新”、“以人为本”、“卓越高效”的价值观，将不断升级核心技术，以优秀的产品提高市场渗透力，成为全球医生和患者信赖的首选品牌。。